baber/WOPTO huggingface dataset:
Patent PT-1456593-E (PT)
Title: A plate package, method of manufacturing a plate package and plate heat exchanger comprising a plate package
Inventor: BLOMGREN RALF
IPC: F28D9/02
Filed: 2002-12-13
Abstract: The invention refers to a plate package for a plate heat exchanger, a method for manufacturing a plate package, a use of a plate package, and a plate heat exchanger. The plate package includes a plurality of heat exchanger plates ( 1 ), which are stacked on each other and which each includes a number of portholes. The plates ( 1 ) are compression molded and permanently connected to each other in a number of joints in such a manner that the plates between each other form a first passage for a first fluid and a second passage for a second fluid. The plate package is designed to permit at least one of the fluids to flow through the respective passages at a predetermined maximum working pressure. The plate package has an increased strength achieved by subjecting at least one of the passages to at least a local inner plastic deformation of the plate package.
Patent PT-1502631-E (PT)
Title: Card deck reader
Inventor: SOLTYS RICHARD
IPC: A63F13/00
Filed: 2000-04-19
Abstract: A system automatically monitors playing and wagering of a game, including the gaming habits of players and the performance of employees at least partially by tracking the movement of chips bearing identifiers. A chip tray reader images the contents of a chip tray, while a table reader images chips on the gaming table. Chip identifiers may be associated with customer or player identifiers, the customer's or player's names may or may not be known. The system detects customer or player behavior such as prohibited playing and wagering patterns, and determines the win/loss percentage of the players and the dealer, as well as a number of other statistically relevant measures. The measurements provide automated security and real-time accounting. The measurements also provide a basis for automatically allocating complimentary player benefits.
Patent PT-1541041-E (PT)
Title: Dietary compositions against stress
Inventor: LUDOVIC PREDAL
IPC: A23L33/15
Filed: 2004-12-10
Abstract: Pharmaceutical or dietetic compositions comprise an oil-soluble magnesium salt of an organic acid, taurine, arginine, B vitamins and an excipient or carrier. ACTIVITY : Tranquilizer. No biological data available. MECHANISM OF ACTION : None given.
Patent PT-1597564-E (PT)
Title: Method and system for inspecting packagings
Inventor: LANDMAN BERNARDUS CORNELIS JOHANNES
IPC: G01N21/90
Filed: 2004-02-27
Abstract: The present invention relates to a method for inspecting packagings for a liquid product, such as drinks, including: setting a packaging into rotation, irradiating the packaging during the rotation with a radiation of a predetermined wavelength, making at least one series of at least two recordings of at least a part of the content of the packaging during the rotation, with an image recording device suitable for making recordings at the predetermined wavelength.
Patent PT-1757247-E (PT)
Title: Dental stick
Inventor: IZMAYLOV VIKTOR IVANOVICH
IPC: A61C15/02
Filed: 2004-05-18
Abstract: The invention relates to medicine, in particular to stomatology. The inventive dental stick comprises a holder (1) provided with oppositely deflected massaging (2) and cleaning elements tapered towards the ends thereof. Said holder is embodied such that it is inflectionally bent in the middle section thereof and two symmetrical oppositely shifted with respect to a symmetry axis (6) segments are formed. Said symmetrical segments of the holder (1) have circular cross sections (7) reducing away from the middle segments of the holder towards the massaging elements (2). Said massaging (2) and cleaning elements are formed by two flat faces which are perpendicular to the holder axis plane. The massaging elements are deflected to the sides which are opposite to the shift of the holder symmetrical segments with respect to the symmetry axis (6). The cleaning elements are provided with round expansions oppositely oriented with respect to the holder axis plane. The surfaces of the massaging elements which are opposite to the expansion direction of the corresponding cleaning element are wave-shaped.
Patent PT-1808331-E (PT)
Title: Belt guide
Inventor: VERTEGAAL HENK
IPC: B60N2/28
Filed: 2007-01-12
Abstract: A child vehicle seat with at least one seat belt guide 6, the guide being adjustable in at least one direction, preferably the width (horizontal) direction. The seat belt guide may move simultaneously in two directions: vertical and horizontal. Two or more guides may be provided wherein adjustment of one guide causes the adjustment of one or more of the other guides. There may be two guides positioned on each side of the child seat. Various different embodiments are disclosed.
Patent PT-1908374-E (PT)
Title: Synchronous office chair
Inventor: CURIGER ERWIN
Filed: 2007-09-26
Abstract: The office chair has a seat support (2) implementing a tilting movement about a tilting axis (4) with a clamp (5). A rear part (3) implements another tilting movement about a virtual axis (13) with a rear bracket (6), where the latter tilting movement is approximately two or three times larger than the former tilting movement in accordance to amount and at the same time implements a translatory movement. A momentary pivotal point of the latter tilting movement lies in a constant distance over a rear middle part of the seat support.
Patent PT-2076450-E (PT)
Title: Bottle for containing fluids, particularly for pharmaceutical products or the like
Inventor: FONTANA ANTONIO
IPC: B65D47/20
Filed: 2007-02-02
Abstract: A squeezable bottle containing fluids has a mouth for dispensing the fluid. An elastic valve is retained between a closing support retainer and a containment ring. The closing support retainer is secured to the mouth of the bottle and to the elastic valve and has passages for fluid through itself. The containment ring prevents the elastic valve from expanding too far outwardly over at least some of the valve's surface. A fluid passage is formed between the elastic valve and a rigid cap that leads to a dispensing opening. The dispensing opening is sealed by a round disc which is integrally formed with the elastic valve and seats on seat on the cap. This arrangement allows the contents of the bottle to remain sanitary over time.
Patent PT-2055263-E (PT)
Title: Method of forming medical devices; intravascular occlusion devices
Inventor: AMPLATZ CURTIS
IPC: A61F2/00
Filed: 1995-07-10
Abstract: A medical device formed of a metal fabric and having an expanded configuration and a collapsed configuration, wherein the medical device is collapsed for deployment through a catheter and, upon exiting the distal end of the catheter in a patient's channel, will resiliently substantially return to its expanded configuration, the medical device having a generally tubular middle portion and a pair of disk-shaped expanded diameter portions, with one expanded diameter portion positioned at either end of the middle portion.
Patent PT-717739-E (PT)
Inventor: KERRIGAN FRANK
IPC: A61K31/357
Filed: 1994-09-01
Abstract: PCT No. PCT/EP94/02904 Sec. 371 Date Jun. 5, 1996 Sec. 102(e) Date Jun. 5, 1996 PCT Filed Sep. 1, 1994 PCT Pub. No. WO95/07274 PCT Pub. Date Mar. 16, 1995Compounds of formula I    <IMAGE>  I  and pharmaceutically acceptable salts thereof in which A is methylene or -O-; B is methylene or -O-; and g is 0, 1, 2, 3 or 4; R1, R2, R3, R4, U, Q and T are defined in claim 1. The compounds have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, Parkinson's disease, obesity, hypertension, Tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, obsessive-compulsive behaviour, panic attacks, eating disorders and anorexia, cardiovascular and cerebrovascular disorders, non-insulin dependent diabetes mellitus, hyperglycaemia, constipation, arrhythmia, disorders of the neuroendocrine system, stress, prostatic hypertrophy, and spasticity.
Patent PT-696287-E (PT)
Inventor: MONGELLI NICOLA
IPC: A61P29/00
Filed: 1995-02-08
Abstract: PCT No. PCT/EP95/00444 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Feb. 8, 1995 PCT Pub. No. WO95/23806 PCT Pub. Date Sep. 8, 1995Subject of the present invention are new ureido derivatives of naphthalenephosphonic acids having the following formula (I)    <IMAGE>  (I)    <IMAGE>   wherein each of m and n, which are the same, is an integer of 1 to 4; each of p and q, which are the same, is an integer of 1 to 3; and each of the R groups, which are the same, is a free or esterified phosphonic acid group; and the pharmaceutically acceptable salts thereof.
Patent PT-786980-E (PT)
Inventor: AHLSTRAND OVE
IPC: A61F13/15
Filed: 1995-10-18
Abstract: The invention relates to a diaper of the kind including outer and inner layers enclosing an absorbing layer, an absorbing body or the like, wherein at least one recess is arranged in the absorbing layer and a liquid passage in line with said recess at the inner covering layer. In addition to the recess in the absorbing layer, there are a number of channels extending from the recess forming together with the recess a storage space defined by the outer and inner layers of the diaper for temporary receiving liquid not yet absorbed and providing an extended liquid absorbing edge surface.
Patent PT-959899-E (PT)
Title: Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation
Inventor: BAZIN HERVE
IPC: C07K16/28
Filed: 1996-08-16
Abstract: The present invention relates to a LO-CD2a antibody and methods of using such antibodies or molecules that bind to the same epitope (or a portion thereof) to prevent and inhibit an immune response in human patients, preferably, where the immune response is mediated by the activation and proliferation of T cells or natural killer cells. The administration of an effective amount of the LO-CD2a antibody to a human patient will prevent or inhibit graft rejection, graft versus host disease or autoimmune disease.
Patent PT-938535-E (PT)
Inventor: GERMANAUD LAURENT
IPC: C10L10/18
Filed: 1997-09-17
Abstract: PCT No. PCT/FR97/01634 Sec. 371 Date Jun. 16, 1999 Sec. 102(e) Date Jun. 16, 1999 PCT Filed Sep. 17, 1997 PCT Pub. No. WO98/12283 PCT Pub. Date Mar. 26, 1998The invention concerns a detergent and anti-corrosive additive for engine fuels, in particular gas oil, containing amide or imide functions characterised in that it is obtained by mixing wt. 60 to 90% of a compound A consisting of at least one carboxylic polyalkenyl, diacid or anhydride, of average molecular mass between 200 and 3000, wt. 0.1 to 10% of a compound B consisting of at least one carboxylic compound, monoacid or anhydride, containing 1 to 6 carbon atoms per chain and 10 to 30% of a compound C consisting of at least one primary polyamine of general formula H2N-[-(CHR1-(CH2)p-CHR2)n-NH]m-H, the mol ratios A/B/C corresponding to 1/(0.1 to 1)/(1 to 3), A/B/C never being 1/1/1.
Patent PT-885013-E (PT)
Inventor: MAYR ANTON
IPC: A61K35/76
Filed: 1997-04-14
Abstract: The use is disclosed of multipotent parapox immunity inducers from attenuated, non-immunogenic pox or parapox viruses (pox inducers) to produce medicaments with new indication ranges in human medicine.
Patent PT-1017675-E (PT)
Inventor: HAUSHEER FREDERICK H
IPC: A61P35/02
Filed: 1998-02-11
Abstract: This invention relates to novel derivatives of camptothecin, and will, particularly to derivatives having a substitution at the C-7 position, or at one of the C-9, C-10, C-11 or C-12 positions, or to disubstituted derivatives having a first substitution at C-7 and a second at one of C-9, C-10, C-11 or C-12. The invention also includes methods of using the compounds as Topoisomerase I inhibitors to treat patients with cancer. The invention also includes pharmaceutical formulations which consist of the novel compounds in solution or suspension with one or more pharmaceutical excipients or diluents.
Patent PT-977539-E (PT)
Inventor: SALMON MICHAEL
IPC: A01N37/20
Filed: 1998-04-23
Abstract: A preservative system comprising iodopropynyl butyl carbamate and phenoxyethanol at a weight ratio of iodopropynyl butyl carbamate to phenoxyethanol within the range of about 1:90 to about 1:400 shows a broad anti-microbial effect and can permit use of the preservative system at a low level in end use products such as personal care products.
Patent PT-1088098-E (PT)
Title: Medicament for treating hiv-infected mammals
Inventor: ERICKSON JOHN W
IPC: C12Q1/37
Filed: 1999-06-23
Abstract: The present invention provides an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity relative to its predecessor. The present invention further provides a continuous fluorogenic assay for measuring the anti-HIV protease activity of protease inhibitor. The present invention also provides a method of administering a therapeutic compound that reduces the chances of the emergence of drug resistance in therapy.
Patent PT-1119997-E (PT)
Inventor: HAUMONT SERGE
IPC: H04L12/56
Filed: 1999-10-05
Abstract: In conventional cellular systems, the identifier of network elements (SGSN) allocating a temporary identity (TLLI) to a mobile station (MS) can be derived from the identities of the cells they serve. In the future, this assumption may no longer be valid. One paging area could be handled by several network elements, such as SGSN nodes, or one network element could serve many paging areas. When the mobile station changes its paging area, the new supporting network element may have trouble in determining the old supporting network element on the basis of the paging area identifier. It is also possible for two supporting network elements to allocate the same TLLI to two different mobile stations. Therefore the network element (SGSN, BSC, RNC) allocating a temporary identity (TLLI) to a mobile station (MS) should incorporate at least part of its own identifier (NEI) into the temporary identity (TLLI).
Patent PT-1134219-E (PT)
Inventor: MAKOTO TAKEMURA
IPC: C07D401/04
Filed: 1999-11-22
Abstract: This invention provides a quinolone derivative which exerts strong antibacterial action upon various bacteria and has high safety, and it relates to a compound having a structure of formula (I), its salts and hydrates thereof: <CHEM> äR<1> and R<2>: hydrogen, alkyl; n: 1 to 4; Q: following structure (Ia): <CHEM> ÄR<3>: alkyl, alkenyl, halogenoalkyl, cyclic alkyl, aryl, heteroaryl, alkoxyl, alkylamino; R<4>: hydrogen, alkylthio; R<5>: hydrogen, amino, hydroxyl, thiol, halogenomethyl, alkyl, alkenyl, alkynyl, alkoxyl; X<1>: halogen, hydrogen, A<1>: nitrogen, structure of formula (II): <CHEM> (X<2>: hydrogen, amino, halogen, cyano, halogenomethyl, halogenomethoxyl, alkyl, alkenyl, alkynyl, alkoxyl; R<4> and R<3> or X<2> and R<3> may together form a cyclic structure; Y: hydrogen, various ester forming groupsÜü.
Patent SG-64891-G (SG)
Title: Optical component for fibre-optical transmission systems
IPC: G02B26/00
Filed: 1991-08-12
Abstract: The invention relates to optical components for fiber-optic transmission system, e.g. attenuation element, filter, power divider, comprising at least two supports 50,51 for the fibers 53,54 and an adjusting member 52 movable therebetween. The invention is based on the object to provide an optical component of this kind suitable for remote control. The invention provides that the supports are formed as guide plates 50,51 and that the adjusting member is formed as adjustment plate 52 of dielectric material, that the adjustment plate 52 is movable in a guide space 57 formed between the guide plates 50, 51, and that at least one support plate 50,51 is provided with at least two electrode surfaces 55,56 building-up a dielectric field, said electrode surfaces 55, 56 being connected to a control system for voltage supply.
Patent IE-900090-L (IE)
Title: Transdermal acrylic multipolymer drug delivery system
IPC: B26F1/44
Filed: 1990-01-10
Abstract: A dermal composition comprising a drug, a multipolymer of ethylene-vinyl acetate, an acrylic polymer, and optionally one or more monomers, a natural or synthetic rubber and a tackifying agent. The ratio of the multipolymer to the rubber is, respectively, about 1:1 to about 10:1 and more preferably, 1:1 to 5:1 and more preferably 3:1. The dermal composition can optionally contain a cross linking agent, tackifiers, penetration enhancers and other ingredients known for use in adhesives for the transdermal delivery of drugs. The dermal compositions can be produced by a variety of methods known in the preparation of drug containing adhesive preparations including the homogenous mixing of the multipolymer, drug and optional crosslinking agent and additional ingredients in solution or suspension or emulsion followed by removal of excess solvent.
Patent IE-35023-L (IE)
Title: Fluorene/fluorenone bis-basic ketones
IPC: C07C49/813
Filed: 1971-03-18
Abstract: The novel bis-basic ketones of fluorene and fluorenone of the present invention have antiviral activity when administered orally and parenterally. These compounds are represented by the following formula: <IMAGE> wherein Z is oxygen or H2; each A is a straight or branched alkylene chain having from 1 to about 6 carbon atoms; and each Y is A. the group <IMAGE> wherein R1 and R2 are individually hydrogen, (lower)alkyl having from 1 to about 6 carbon atoms, cycloalkyl having from 3 to 6 carbon atoms, alkenyl of from 3 to 6 carbon atoms and having the vinyl unsaturation in other than the 1-position of the alkenyl group; or B. the group <IMAGE> WHEREIN N IS A WHOLE INTEGER FROM 4 TO 6, AND R3 is hydrogen, (lower)alkyl of 1 to about 4 carbon atoms, phenyl, or benzyl and can be linked to any one of the carbon atoms of the heterocyclic group; or C. the group <IMAGE> wherein X is oxygen or NR4, and R4 is hydrogen or (lower)alkyl of from 1 to about 4 carbon atoms; or D. the group <IMAGE> WHEREIN P IS A WHOLE INTEGER FROM 2 TO 3, AND M IS A WHOLE INTEGER FROM 1 TO 2; OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT OF SAID BASE.
[US4064347A]
Patent IE-780493-L (IE)
Title: Voltage setting.
IPC: C25D21/12
Filed: 1978-03-10
Abstract: An arrangement for controlling the electric energy supply rate to an electroplating installation includes a positionally adjustable actuating member connected to a carrier which supports workpieces to be electroplated in an electroplating vat, and a sensor mounted on the vat and operative for detecting the extent of positional adjustment of the actuating member and generating a signal proportionate thereto. The signal is then transmitted to a source of direct electric current to be used thereat for controlling the output rate of the source. The actuating member is a setting screw which is threaded into a sleeve which, in turn, is mounted on a bracket rigidly connected to the carrier, while the sensor includes a housing rigidly mounted on a lug of the vat, and a potentiometer accommodated in the housing and having a detecting rod which extends beyond the housing and into the path of displacement of the setting screw. The housing is sealingly closed by a sealing cable connector, on the one hand, and by a bellows-shaped protective member sealingly connected to the housing and surrounding the detecting rod of the potentiometer, on the other hand. A spring urges the detecting rod toward its extended position relative to the housing. A cable passes through the cable connector and transmits the signals generated in the potentiometer in dependence on the extent of displacement of the detecting rod to the source to control the same.
[US4134819A]
Patent IE-780550-L (IE)
Title: Purification of lactose
IPC: C13K5/00
Filed: 1978-03-20
Abstract: Lactose crystals of improved purity and reduced color are obtained by washing the lactose crystals in an alkaline wash-bath having a pH within the range of from about 8.5 to about 12.5. The isolated washed crystals exhibit improved purity particularly in the reduction of nitrogen-containing impurities as evidenced by a reduced total Kjeldahl nitrogen content and a substantially white color.
[US4099983A]
Patent IE-780731-L (IE)
Title: One piece connector
IPC: H01R12/71
Filed: 1978-04-13
Abstract: The plug-connection arrangement, which is suitable for use as an electrical connecting part for batteries, has at least one plug-connection part (10) which is installed in a supporting plate (32), a projection (24) of said plug-connection part (10) protruding through a hole (30) in the supporting plate (32). In order to make it impossible for the contents of the battery to run out, the plug-connection part (10) is of integral construction and has a connection piece (12) which is provided with an integrally formed base wall (22). The projection (24), which is constructed with a closed end piece (28), is integrally formed pointing away from the connection piece (12), the end piece (28) being formed to create a shoulder (27) which is directed outwards and presses against the supporting plate (32). The diameter of said shoulder (27) is greater than that of the hole (30), as a result of which the supporting plate (32) is held between the shoulder (27) and the base wall (22) in a sealing manner, and the plug-connection part (10) is held securely in the supporting plate (32). <IMAGE>
[GB1590603A]
Patent IE-44117-L (IE)
Title: Pharmaceutical compositions
IPC: A61K31/54
Filed: 1976-04-09
Abstract: Novel diuretic and antihypertensive compositions comprising an effective amount of triamterene or 2,4,6-triamino-6-phenylpteridine having the formula <IMAGE> and an effective amount of cyclothiazide or the 1,1-dioxide of 6-chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7- sulfonamide having the formula <IMAGE> and a method of inducing diuresis and antihypertensive activity in warm-blooded animals.
[US4056618A]
Patent IE-32206-L (IE)
Title: Flame retardant hardboard.
IPC: C08L97/02
Filed: 1968-07-22
Abstract: 1,185,330. Flame retardant hardboard. BOWATERS UNITED KINGDOM PAPER CO. Ltd. 26 July, 1968 [26 July, 1967], No. 34299/ 67. Headings D2A and D2B. Flame retardant hardboard is manufactured by forming in a continuous manner, a travelling layer of wet wood fibre, forming on the surface thereof a layer comprising wet asbestos fibre or mica and wood pulp and causing the two layers to combine by removing water therefrom. The asbestos or mica and wood layer may be treated with one or more flame retardant chemicals for example by spraying with an aqueous solution of a flame detardant chemical some of which penetrates through to the wood-fibre layer. The asbestos or mica and wood layers may also contain starch as a binder. In the example a mixture of wood fibre, asbestos fibre, starch and water is supplied to a secondary headbox; from which it is disposed in the form of a layer upon a wet mat of wood pulp formed in the mat forming machine and, following passage through pressure rollers, the upper surface of the lap is sprayed with a flame retardant chemical a solution of which contains urea and formalin some of which passes through the asbestos or mica wood layer to the wood fibre layer.
[GB1185330A]
Patent IE-900914-L (IE)
Title: Plaster used as therapeutic system for the administration of¹active substances to the skin, which exhibits a graduated¹active substance release, process for the production of the¹plaster and the use thereof
IPC: A61L15/44
Filed: 1990-03-14
Abstract: Transdermal patches for controlled release of a drug comprise at least one drug reservoir in contg. with a drug-contg. release-controlling matrix, with a backing layer on the skin-distal side of the matrix and an adhesive layer on the skin-proximal side. The size and posn. of each drug reservoir are such that in at least one direction, the distance between the reservoir and the drug delivery surface of the matrix is greater than the diffusion path length of at least one drug from its reservoir into the matrix during the period of application.